K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.21 SEK 0.17% Market Closed
Market Cap: 323.4m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Karolinska Development AB
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Karolinska Development AB
Accrued Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
K
Karolinska Development AB
STO:KDEV
Accrued Liabilities
kr7.6m
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
1%
Calliditas Therapeutics AB
STO:CALTX
Accrued Liabilities
kr252.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Accrued Liabilities
kr233.8m
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Accrued Liabilities
kr78.5m
CAGR 3-Years
53%
CAGR 5-Years
94%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Accrued Liabilities
kr14.9m
CAGR 3-Years
8%
CAGR 5-Years
38%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Accrued Liabilities
kr19.3m
CAGR 3-Years
79%
CAGR 5-Years
11%
CAGR 10-Years
N/A

See Also

What is Karolinska Development AB's Accrued Liabilities?
Accrued Liabilities
7.6m SEK

Based on the financial report for Jun 30, 2024, Karolinska Development AB's Accrued Liabilities amounts to 7.6m SEK.

What is Karolinska Development AB's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
1%

Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for Karolinska Development AB have been 12% over the past three years , 1% over the past five years , and 1% over the past ten years .

Back to Top